Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Jun 13, 2024 5:03pm
101 Views
Post# 36088036

I pity Buck Henry, so sad of an individual

I pity Buck Henry, so sad of an individual

First, my apologies up front. I rearley get involved in off topic stuff.
That being the prime motivation of Bucy et.al. To discredit this site & any posituve comments.
majority have figured Mr Henry out.
The view meter a clear indicator of that. My last post recieved 139 reads.
bucky 77. Just about 1/2.
My point?
The huckster, clearly has the I.Q. Of a baked potato & zero memory.
Quite a few posts back, I gave my personal history of cancer. Revealing all of my relatives have onky died if cancer. Including my mother & aunts from the same grandparents.
it was replied, I'm quite sure from Bucky " save us your pity, we all know people with cancer"
My point then was certainly not for pity, but context. I know a lot about cancer & cancer treatments.
Now, revealing his huge I.Q. Comes up with a grade school line, suggesting im living in my moms basement etc.
Too bad, perhaps Alzheimer's or just plain lack of memory for Bucky. My mom has been long gone for over 30 years.
ironically , I challenged Buck Henry to post just one point of substance.
That was a few months ago.
so far??
more of the same childish, Ad Hominem non- sense.
perhaps, as was suggested, he is looking in the mirror.
FYI , Bucky. 

I had a very successful working life. Was raised dirt poor. My 25k ++ shares of ONC I consider play money.
i do feel for you, obviously some problems.
if you find it in your jollies  to insult me , at least be consistent.
Back to Onc; 
Another very quiet day. Volume next to zero. No news. 

We have 12; trading days left in this month/ quarter. 17 calendar days.
It was addressed , is still on company's web site.
they will update in this quarter, the following:
MBc planned study details / registrationional study
gobblet cohurt #5, MFol , phase 2 study initiation.
gobblet cohurt #4 anal cancer study expansion. 


The Gobblet studies are in collaboration with Roche.
The MBc study?.. says TBD.

Why very little volume?
The dsy traders for the most part have moved on.
those who understand are in wait & see mode.
Yes, the SP is down. News is needed. 
My biggest regret, back in 2019 was trading @ .88 CDN., actually a bit lower.
My regret, I did not buy a boatload.
i was at that time in- processs of moving. as such was carrying 4 properties.
already owned shares , did buy some more. Looking back? . 

can say that about anything.
What matters is now.
Onc is as close as they have ever been to getting into phase 3. they need $$ to do that.
The TBD? Interesting way of saying, who ever the partner is.
seventeen calendar days.......
Obviously the FDA type C meeting update will determine a lot of how the phase 3 is run.
That in turn will set a much firmer indicator of company value.
Mangement js well aware, news is needed. They can only report things when they happen.
Not before.....

 


 


 

<< Previous
Bullboard Posts
Next >>